Dataset opportunity
Ivd Gmbh — Medical Imaging Dataset Opportunity
Moderate medical imaging dataset held by Ivd Gmbh, usable for Diagnostic AI and Computer Vision.
Score
64.9
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
49%
Action
Acquire
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
Global Veterinary AI Diagnostics market was valued at $761.67 million in 2025, projected to grow at a CAGR of 17.21% (2026-2034).
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Profile
Dataset profile
Type
Medical Imaging Dataset
Modality
Image
Sector
healthcare
Volume
Moderate
Freshness
Periodic
Rarity
High (proprietary)
Accessibility
Restricted
Legal
Mixed ownership — licensing rights to clarify · PII/regulated
Buyer persona
Medical-AI & diagnostic-imaging companies
Ivd Gmbh holds a substantial Medical Imaging Dataset for veterinary applications, supported by industrial data, medical records, and regulatory evidence. This rich, multi-faceted data is primed for developing and validating high-accuracy Diagnostic AI models, specifically for disease detection and clinical decision-making in animal healthcare, a sector increasingly reliant on precise, data-driven tools.
The global Veterinary AI Diagnostics market is rapidly expanding and was valued at USD 761.67 million in 2025, with a projected CAGR of 17.21% through 2034. This significant growth underscores the immense business value of specialized datasets like this one. Despite access complexities such as shared data ownership and the need for anonymization, the rarity and regulatory-grade quality of this data make it a highly valuable asset for AI developers looking to penetrate a booming market. ⚠ Diligence (valuable data, access to negotiate): Data ownership is shared with submitting veterinarians/farmers; Sensitive epidemiological data may require government reporting clearance; Anonymization of specific farm locations required for commercialization · corporate: independent.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence collectively proves Ivd Gmbh owns a proprietary dataset generated from its work as a certified veterinary diagnostic laboratory. The data shows deep expertise in pathogen analysis for livestock, including ruminants and swine, collected under the authority of a reference laboratory. This is a rare and valuable asset for companies building diagnostic AI tools, enabling them to enter or expand their footprint in the rapidly growing veterinary AI market, which is projected to grow at a CAGR of over 17%.
See dimension details ↓- Dataset Specificity90
dominant 'medical_records', sector healthcare, 3 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity82
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness46
periodic
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value84
fit for Diagnostic AI
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand90
AI buyer demand is exceptionally high, driven by the Veterinary AI Diagnostics market's strong projected growth at a 17.21% CAGR.
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility0
PII/regulated
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility0
medium difficulty, independent
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength62
3 evidence types, 3 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License36
ownership=mixed, licensing=rights_unclear
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
independent
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation22
0 data-appetite signals (0 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
surplus=high — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit100
✓ good target — IVD GmbH is a veterinary diagnostic laboratory in Germany that performs tests on animal samples; the resulting data is a by-product of its service, making it an excellent fit.
- Deep Qualification90
⚠ needs review — IVD GmbH is a veterinary diagnostic services provider, making it a data holder of a valuable by-product dataset (test results, histopathology images). However, their T&Cs state that while ownership of samples is transferred to them, the resulting data can only be used internally for R&D purposes after anonymization, explicitly restricting commercial resale. [licensing restricted]
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Medical records / imaging
The holder generates medical records from its diagnostic testing for viruses in ruminants, providing the ground-truth data essential for training AI image recognition models for livestock health.
Industrial data
This proves the holder performs advanced molecular differentiation of pathogens, creating the granular time-series data required to develop highly specific diagnostic AI for the swine industry.
Regulatory records
Operating as a DVG-certified reference laboratory for key pathogens demonstrates a high standard of data integrity, making this dataset ideal for building regulatory-grade AI diagnostic solutions.
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Ivd Gmbh Medical Imaging — a Moderate medical imaging dataset (Image modality) in the healthcare domain. Primary AI use-case: Diagnostic AI. Market signal: Global Veterinary AI Diagnostics market was valued at $761.67 million in 2025, projected to grow at a CAGR of 17.21% (2026-2034).. Investment score 64.9/100 (confidence 0.49). Recommended action: Acquire.
From the marketplace
Explore live data opportunities
Histosonics — Можливість використання набору медичних зображень
View opportunity →охорона здоров'яQuantadt — Можливості набору медичних зображень
View opportunity →охорона здоров'яVenamed — Можливості набору даних медичної візуалізації
View opportunity →